The U.S. Social Security Administration has requested the National Academies of Sciences, Engineering, and Medicine establish an ad hoc committee to conduct a study to review the latest published ...
ORLANDO, Fla. — Recurrent pain episodes are the leading reason for emergency department (ED) visits among patients with sickle cell disease, but adherence to established acute pain management ...
Please provide your email address to receive an email when new articles are posted on . Ninety percent of patients with sickle cell disease survived at least 7 years after allogeneic HCT. A majority ...
While mitapivat also showed a reduction in the primary endpoint of annualized rate of sickle cell pain crises (SCPCs) compared to placebo, this trend did not achieve statistical significance. 40.6% of ...
In its mission to grow the reach of its pyruvate kinase (PK) activator Pyrukynd (mitapivat), Agios Pharmaceuticals has come up short of producing an unequivocal win in the key indication of sickle ...
Trial met primary endpoint of hemoglobin response and key secondary endpoints of change from baseline in hemoglobin concentration and indirect bilirubin Trial showed trend favoring mitapivat but did ...
ABSTRACT: Introduction: Respiratory distress is a frequent reason for consultation in children with sickle cell disease and can lead to complications that can sometimes be life-threatening. In Senegal ...
ABSTRACT: Introduction: Respiratory distress is a frequent reason for consultation in children with sickle cell disease and can lead to complications that can sometimes be life-threatening. In Senegal ...
Apple pie has long been a staple of American culture. However, a recent survey by Hers on Americans’ favorite pie for Thanksgiving found that 77% of respondents call a variety other than apple pie as ...
When Amy Cohen, 29, finished the New York City Marathon, she broke ground as the first person with the illness to run the 26.2 mile race Mass General Brigham Amy Cohen became the first-ever person ...
This video is no longer available. It is described as intense pain shooting throughout your body and has had a history of misdiagnosis and complications as patients are constantly traveling to ...
If you or someone you know has sickle cell disease (SCD), you may have heard of Lyfgenia, one of two gene therapies approved for this condition. Gene therapies are the only treatments for SCD that can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback